Are Diamonds Forever? Insights From 22 Years of Zero-Return Saga
Mint Bangalore|January 02, 2025
Diamonds, synonymous with luxury, captivate investors, but their investment potential tells a different story
Anil Poste

De Beers' 1947 slogan, "A diamond is forever," revolutionized the industry. The ad campaign established diamonds as the most romantic purchase, and the status is still paying off. However, what about their value as investments? Are diamonds really forever?

Mint asked experts to share investing lessons from diamonds' two-decade-long price stagnation and whether modern-day assets like cryptocurrencies will meet the same fate.

Radhika Gupta, MD and CEO, Edelweiss Asset Management Ltd

The key thing is some asset classes can structurally be in decline and not deliver any returns for over 20 years. Commodities are a clear example of this as prices depend on supply and demand, and there's no inherent reason for them to grow over time.

For instance, the diamond market has been disrupted by lab-grown diamonds, which have reduced demand and impacted the value of natural diamonds. This shows how changes in market dynamics or technological advancements can lead to prolonged price stagnation or even a decline.

Unlike equities, commodities don't have a natural growth trajectory and are not long-only assets as they don't create value through advancement.

Equities are different. In a growing economy, firms drive growth through innovation, expansion and productivity, creating long-term value for shareholders, making equities more reliable for wealth creation over time.

While commodities can have a role in a portfolio for diversification or as a short-term hedge against inflation, they are unlikely to deliver steady, long-term growth. Relying on them as the primary driver of wealth may lead to disappointing results.

Esta historia es de la edición January 02, 2025 de Mint Bangalore.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición January 02, 2025 de Mint Bangalore.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE MINT BANGALOREVer todo
Mint Bangalore

Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars

Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects

time-read
3 minutos  |
January 08, 2025
Mint Bangalore

DIAL drops plea over Hindon ops expansion

Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Auto sales rise 9% in 2024 despite headwinds: Fada

Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec

time-read
1 min  |
January 08, 2025
Mint Bangalore

Razorpay Charts Return to India; Eyes Expansion, IPO

Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years

time-read
3 minutos  |
January 08, 2025
Mint Bangalore

Bank profits set to moderate in FY26 as bad assets rise

Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier

time-read
2 minutos  |
January 08, 2025
Mint Bangalore

Lloyds Metals shines on likely gains from acquisition, capex

Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Another tough year for FMCG?

Feeling blue

time-read
2 minutos  |
January 08, 2025
Mint Bangalore

Your fancy, new ETF might be a little too fancy

Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good

time-read
4 minutos  |
January 08, 2025
Mint Bangalore

Risks to economy escalating in 2025, cautions SBICAPS

Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report

time-read
1 min  |
January 08, 2025
Mint Bangalore

Intas Pharma bags another overseas company

Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.

time-read
1 min  |
January 08, 2025